A pharmaceutical company that focuses on novel therapeutics for the treatment of diseases and disorders of the central nervous system.
BATS data provided in real-time. NYSE, NASDAQ and AMEX data delayed 15 minutes.
Real-Time prices provided by BATS. Market data provided by Interactive Data.
Company fundamental data provided by Morningstar. Earnings Estimates and Analyst Ratings provided by Zacks.
SEC Filings and Insider Transactions provided by Edgar Online.
Powered and implemented by Interactive Data Managed Solutions. Terms & Conditions
RSS Headlines
Fool UK
Recs
The new frontier for QCOR's flagship drug, Acthar, is the NS application. If phase IV testing proves out, Acthar could be a last line of defense treatment for NS patients before dialysis.